[HTML][HTML] Long COVID-19 and postural orthostatic tachycardia syndrome-is dysautonomia to be blamed?

KR Chadda, EE Blakey, CLH Huang… - Frontiers in …, 2022 - frontiersin.org
While the increased arrhythmic tendency during acute COVID-19 infection is recognised, the
long-term cardiac electrophysiological complications are less well known. There are a high …

[HTML][HTML] The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET

R Talarico, S Aguilera, T Alexander, Z Amoura… - Nature Reviews …, 2021 - nature.com
During the COVID-19 pandemic, the need to provide high-level care for a large number of
patients with COVID-19 has affected resourcing for, and limited the routine care of, all other …

[HTML][HTML] Nanomedicine: a diagnostic and therapeutic approach to COVID-19

A Sharma, K Kontodimas, M Bosmann - Frontiers in Medicine, 2021 - frontiersin.org
The SARS-CoV-2 virus is causing devastating morbidity and mortality worldwide.
Nanomedicine approaches have a high potential to enhance conventional diagnostics …

[HTML][HTML] Challenges and opportunities from targeting inflammatory responses to SARS-CoV-2 infection: a narrative review

V Lariccia, S Magi, T Serfilippi, M Toujani… - Journal of Clinical …, 2020 - mdpi.com
The novel coronavirus disease 2019 (COVID-19) is a global pandemic that continues to
sweep across the world, posing an urgent need for effective therapies and prevention of the …

Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: A meta-review of systematic reviews and an updated meta-analysis

T Chivese, OAH Musa, G Hindy, N Al-Wattary… - Travel Medicine and …, 2021 - Elsevier
Objective To synthesize findings from systematic reviews and meta-analyses on the efficacy
and safety of chloroquine (CQ) and hydroxychloroquine (HCQ) with or without Azithromycin …

[HTML][HTML] Cardiac manifestations in patients with COVID-19: a scoping review

S Peiris, P Ordunez, D DiPette, R Padwal, P Ambrosi… - Global Heart, 2022 - ncbi.nlm.nih.gov
Background: Coronavirus disease 2019 (COVID-19), commonly affects the lungs, but the
involvement of other organs, particularly the heart, is highly prevalent as has been reported …

The antimicrobial and immunomodulatory effects of Ionophores for the treatment of human infection

G Li, DMP De Oliveira, MJ Walker - Journal of Inorganic Biochemistry, 2022 - Elsevier
Ionophores are a diverse class of synthetic and naturally occurring ion transporter
compounds which demonstrate both direct and in-direct antimicrobial properties against a …

Pediatric coronavirus disease 2019: clinical features and management

PK Sahi, U Jhamb, A Dabas - Indian pediatrics, 2021 - Springer
There is a lack of clarity regarding management of COVID-19 infection in children. This
review aims to summarize the key clinical presentations and management of Pediatric …

Combating the Progression of Novel Coronavirus SARS-CoV-2 Infectious Disease: Current State and Future Prospects in Molecular Diagnostics and Drug Discovery

A Kumar, A Sharma, NV Tirpude… - Current Molecular …, 2023 - ingentaconnect.com
A highly infectious and life-threatening virus was first reported in Wuhan, China, in late 2019,
and it rapidly spread all over the world. This novel virus belongs to the coronavirus family …

[HTML][HTML] Histopathological and molecular links of COVID-19 with novel clinical manifestations for the management of coronavirus-like complications

A Sood, O Bedi - Inflammopharmacology, 2022 - Springer
Abstract Coronavirus disease 2019 (COVID-19) causes transmissible viral illness of the
respiratory tract prompted by the SARS-CoV-2 virus. COVID-19 is one of the worst global …